New York State Common Retirement Fund
MTNB icon

New York State Common Retirement Fund’s Matinas BioPharma MTNB Stock Holding History

New York State Common Retirement Fund’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-75
Closed -$43K – 3196
2018
Q1 		$43K Hold
75
– – ﹤0.01% 3037
2017
Q4 		$65K Hold
75
– – ﹤0.01% 3030
2017
Q3 		$74K Hold
75
– – ﹤0.01% 3038
2017
Q2 		$95K Buy
+75
New +$151K ﹤0.01% 3097

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Raymond James Financial Services Advisors
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Element Capital Management
Element Capital Management New York $3.2B AUM 29.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
BlueCrest Capital Management
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

New York State Common Retirement Fund's MTNB Position: Q2 2018 in Review

New York State Common Retirement Fund sold out of Matinas BioPharma (MTNB) in Q2 2018, closing a stake of 75 shares — an estimated $43K sold.

New York State Common Retirement Fund first reported a position in MTNB in Q2 2017 and held it in 4 quarters. The position peaked at $95K in Q2 2017. 38 funds tracked by Wall St. Rank hold MTNB as of Q2 2018.

  • New York State Common Retirement Fund reported no remaining Matinas BioPharma position as of Q2 2018 after selling out during the quarter.
  • New York State Common Retirement Fund sold 75 Matinas BioPharma shares in Q2 2018, an estimated $43K.
  • New York State Common Retirement Fund first reported a position in Matinas BioPharma in Q2 2017 and held it in 4 quarters.
  • New York State Common Retirement Fund's Matinas BioPharma position peaked at $95K in Q2 2017.
  • 38 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2018.

Based on New York State Common Retirement Fund's 13F filing for Q2 2018, filed 10 Aug 2018.